In vitro studies revealed that NUCB2/NESF-1 increases invasion, migration, and proliferation in the colon, bladder, papillary thyroid, endometrial, renal, breast cancer cells, and glioblastoma [41,46,50,58]. This evidence concerns the gene NUCB2 and glioblastoma.